Add Company
Join Now

HGF Limited Revenue and Competitors

License our Company Data API

Leeds, UK

Location

N/A

Total Funding

Legal

Industry

Estimated Revenue & Valuation

  • HGF Limited's estimated annual revenue is currently $230.5M per year.(i)
  • HGF Limited's estimated revenue per employee is $337,500

Employee Data

  • HGF Limited has 683 Employees.(i)
  • HGF Limited grew their employee count by 11% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.9M15816%N/AN/A
#2
$23M8535%N/AN/A
#3
$0.3M20%N/AN/A
#4
$68.6M2316%N/AN/A
#5
$32.9M1223%N/AN/A
#6
$71.9M2421%N/AN/A
#7
$4M21-12%N/AN/A
#8
$50.8M1719%N/AN/A
#9
$10.4M48-16%N/AN/A
#10
$44.3M14910%N/AN/A
Add Company

HGF is a firm of Patent and Trade Mark Attorneys with offices in Aberdeen, Amsterdam, Basel, Birmingham, Edinburgh, Glasgow, Leeds, London, Manchester, Munich, Newcastle, Nottingham, Oxford, Sheffield, The Hague, Westport and York. The firm specialises in protecting intellectual property for research institutions and businesses ranging from SMEs to multinationals. Sister law firm, HGF Law, has specialist IP solicitors experienced in exploiting and enforcing intellectual property rights. The UK's 2nd largest filer of PCT and CTMs.

keywords:N/A

N/A

Total Funding

683

Number of Employees

$230.5M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

HGF Limited's People

NameTitleEmail/Phone
1
Credit ControllerReveal Email/Phone
2
Learning and Development ManagerReveal Email/Phone
3
Patent Formalities OfficerReveal Email/Phone
4
Patent DirectorReveal Email/Phone
5
Senior European Patent AttorneyReveal Email/Phone
6
Executive Assistant to the Chair & Board and Central Support ManagerReveal Email/Phone
7
PartnerReveal Email/Phone
8
PartnerReveal Email/Phone
9
PartnerReveal Email/Phone
10
Senior European Patent AttorneyReveal Email/Phone

HGF Limited News

2022-03-30 - Athira Pharma Doses First Subject in Phase 1 Clinical Trial of HGF/MET Positive Modulator, ATH-1020, an Orally Available Small Molecule for Neuropsychiatric Conditions

Our novel approach targeting HGF/MET, and ATH-1020's unique pharmacology ... These risks and uncertainties include, but are not limited to,...

2022-03-22 - Therapeutic Targeting of Stromal-Tumor HGF-cMET Signaling in an Organotypic Triple Negative Breast Tumor Model

Therapeutic Targeting of Stromal-Tumor HGF-cMET Signaling in an ... cancer (TNBC) that have a rich stroma and limited targeted therapies.

2022-03-22 - Grant Certificates At The EPO Go Digital - Intellectual Property ...

Specialist advice should be sought about your specific circumstances. AUTHOR(S). HGF Limited. HGF Ltd.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75M7165%N/A
#2
$240.9M7205%N/A
#3
$259.2M729N/AN/A
#4
$277.1M733-2%N/A
#5
$75M7335%N/A